An inhalable dendrimer-based delivery platform for the targeted treatment of primary and secondary lung cancers

  • Kaminskas, Lisa, (Primary Chief Investigator (PCI))
  • Porter, Christopher (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/05/1430/04/17

Funding

  • Cancer Australia: AUD452,383.00